Skip to content

Clinical trials

Breast Neoplasms trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Country / region: Belgium Clear all

520 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20018
20026
200322
20045
200516
200617
200722
200816
200928
201017
201124
201221
201330
201426
201519
201616
201726
201822
201926
202019
202122
202228
202324
202420
202519
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed311
Recruiting59
Active, not recruiting57
Terminated53
Unknown status31
Withdrawn6
Approved for marketing2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals40
Hoffmann-La Roche35
Jules Bordet Institute35
AstraZeneca29
Pfizer28
Universitaire Ziekenhuizen KU Leuven28
Eli Lilly and Company25
European Organisation for Research and Treatment of Cancer - EORTC25
University Hospital, Ghent15
ETOP IBCSG Partners Foundation13

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms520
Neoplasm Metastasis56
Neoplasms50
Colorectal Neoplasms20
Carcinoma, Non-Small-Cell Lung19
Ovarian Neoplasms19
Triple Negative Breast Neoplasms19
Brain Neoplasms15
Lung Neoplasms15
Prostatic Neoplasms15

Trials

Showing 51 to 75 of 520. Each trial links to its page on Pharma Observatory.

420 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.